Natalizumab an effective and safety therapy in patients with multiple sclerosis

• In: Hospital Pharmacy Posters
• At: Lisbon (Portugal) (2010)
• Type: Poster
• Poster code: HPS-P-021
• By: TORRES, Maria Alexandra (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, Coimbra, Portugal)
• Co-author(s): Campelo, Isabel (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
  Rodrigues, Ana Isabel (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
  Rocha, Marilia (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
  Cabral, Maria Adelaide (Hospitais da Universidade de Coimbra - Serviços Farmacêuticos, COIMBRA, Portugal)
  
• Abstract:

  Objective: The aim of the present study was to evaluate the effectiveness and safety of the new therapeutic agent, Natalizumab. Design: A three year (2007-2009) retrospective study of patients admitted to the three Neurology wards. Data were collected by physicians and the neurology pharmacist during the outpatient visit. Main Outcome Measures:..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login